<DOC>
	<DOCNO>NCT00519428</DOCNO>
	<brief_summary>This study utilize randomized double-blind design evaluate whether initial treatment two anti-depressant medication ( escitalopram bupropion ) result rapid remission great over-all remission rate either monotherapy 240 depressed subject .</brief_summary>
	<brief_title>Does Dual Therapy Hasten Antidepressant Response ?</brief_title>
	<detailed_description>Depression major public health problem due prevalence accompany dysfunction cost . Depression undertreated , even treatment adequate effective , source delay current pharmacologic strategy include : mechanistic delay , relate physiologic behavioral effect antidepressant ; dose delay identify effective dose ; programmatic delay identify effective agent use sequential monotherapy . This study randomize 240 patient DSM-IV Major Depressive Disorder 12 week double blind treatment combine escitalopram bupropion antidepressant administer alone evaluate whether combined escitalopram bupropion result rapid remission great over-all remission monotherapy . Preclinical clinical study suggest bupropion might prevent one mechanistic delay inherent escitalopram monotherapy . Rapid dose escalation may counter dose delay . The simultaneous use two know antidepressant medication may alleviate programmatic delay inherent usual sequential monotherapy . Six month follow careful assessment adverse event address tolerability , acceptability , sustainability , pharmacoeconomic concern . If successful , study might significant impact clinical practice , public health , depression 's cost consequence .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Men woman age 1865 2 . Major Depressive Disorder primary diagnosis 3 . Physically healthy 4 . Signs inform consent 5 . Montgomery Asberg Depression Rating Scale ( MADRS ) &gt; = 22 1 . Bipolar Disorder ( ie , Bipolar I , Bipolar II , Bipolar NOS ) 2 . Lifetime history psychosis 3 . Current ( ie , last 6 month ) drug alcohol abuse dependence ( except nicotine ) 4 . Currently take effective antidepressant medication 5 . Prior adequate treatment current depressive episode SSRI , BUP BUP + SSRI ( `` adequate '' define &gt; = 4 week take &gt; = 2/3 PDR maximal dose ) 6 . Most recent antidepressant within 5 week fluoxetine 1 week others 7 . Currently take medication contraindicate either study medication 8 . Life time history anorexia bulimia 9 . Life time history seizure know increased seizure risk ( e.g. , history significant brain trauma , take proconvulsant medication , know anatomical brain lesion ) 10 . Currently take psychoactive medication deem necessary ( include limited anticonvulsant , antidepressant , antipsychotic , steroid , Bblockers ) ; occasional use hypnotic ( ie , less three time per week ) allow 11 . Unstable medical condition ( ie , condition adequately stabilize &gt; = 3 month ) 12 . Prior intolerance ESC BUP 13 . Inadequate understanding English ( US site ; Canadian site permit French fluency ) 14 . Currently pregnant breastfeeding ; fecund woman use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>depression</keyword>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>